37 episodes of Staphylococcus aureus bacteremia (SAB) in children and adolescents with acute lymphoblastic leukemia (ALL) were analyzed. 25 were associated with an identifiable source of infection: pneumonia (9), cellulitis (11), osteomyelitis (2), ear infection (2), urinary tract infection (1). The absolute neutrophil count was less than 1,000/mm3 at the onset of 29 episodes. 6 patients had a bacterial re-infection after the treatment for SAB was stopped. 5 patients had fungal infection discovered at autopsy. 7 patients died within 4 days of admission. Gram-negative superinfection occurred in 6 patients treated with multiple antibiotics whereas no patient among those treated with a single antibiotic developed superinfection. This was not a statistically different difference.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.